Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer Nurs. 2010 May–Jun;33(3):201–212. doi: 10.1097/NCC.0b013e3181c75f2a

Table 2.

Demographic, Disease, and Treatment Characteristics of the Patients (n=73)

Characteristic Mean (Standard Deviation)

Age (years) 55.1 (11.0)

Education (years) 16.2 (2.7)

Karnofsky Performance Status Score 87.7 (12.4)

Number of comorbidities 5.3 (2.6)

Weight (pounds) 165.2 (43.6)

Body mass index 27.4 (7.3)

Hemoglobin (g/dl) 12.7 (1.2)

Hematocrit (%) 37.5 (3.4)

Lives alone 41.0%

Marital status
  Married/partnered 28.8%
  Divorced/separated 30.1%
  Other 41.1%

Ethnicity
  Non-white 30.0%
  White 70.0%

Employed
  Yes 45.0%
  No 55.0%

Children at home 22.0%

Stage
  Localized 56.2%
  Locally advanced 43.8%

Any chemotherapy received 55.0%

Lymph node dissection 49.0%

Hormonal therapy prior to diagnosis 44.0%

Total dose of RT (cGys) 5829 (438.3)

Mean symptom severity scores at baseline
  LFS score for evening fatigue 4.9 (1.8)
  LFS score for morning fatigue 2.9 (2.1)
  GSDS score 44.7 (21.7)
  CES-D score 12.0 (9.2)
  Trait Anxiety Inventory score 36.2 (11.3)
  State Anxiety Inventory score 33.7 (12.9)

Percentage of patients with pain 49.3%

Abbreviations: CES-D = Center for Epidemiologic Studies Depression Scale, GSDS = General Sleep Disturbance Scale, LFS = Lee Fatigue Scale, RT = radiation therapy